This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morikawa, K. Articles by Fidler, I. J. Search for Related Content PubMed PubMed Citation Articles by Morikawa, K. Articles by Fidler, I. J.

Mechanisms of Combined Effects of -Interferon and 5-Fluorouracil on Human Colon Cancers Implanted into Nude Mice¹

Department of Cell Biology [K. M., D. F., Y. M. D., S. M. W., I. J. F.] and Division of Medicine [B. L., J. V. G.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The purpose of these studies was to determine the possible mechanisms responsible for the therapeutic effects of systemic administration of 5-fluorouracil (FUra) and -interferon on disseminated human colon cancer. We used several human carcinoma cell lines that were established from different surgical specimens. Some lines were selected in nude mice for increased metastatic potential, and one line was selected in vitro for resistance to human recombinant -interferon (r-IFN-). In initial in vitro studies, FUra was cytostatic against all the human cell lines but did not produce cytolysis in any of the lines tested. The two r-IFN- were species specific for both antitumor and immunomodulatory effects. Human r-IFN- produced cytostatic and cytolytic effects against sensitive human colon carcinoma cells but did not activate tumoricidal properties in mouse macrophages. In contrast, mouse r-IFN- had no direct cytotoxic effects against any of the human colon carcinoma lines but did activate tumoricidal properties in mouse macrophages. Human colon carcinoma cells (sensitive or resistant to human r-IFN-) were implanted into the spleens of nude mice. Three days later, we began treatments with FUra and human or mouse r-IFN-. In all experiments, the combination of FUra with mouse r-IFN- produced the best therapeutic effects against growth of the cells in the spleen and in the liver. Because the mouse r-IFN- is devoid of direct antitumor effects (against human tumor cells) but is a potent macrophage activator, these results suggest that the antitumor effects were due to direct antitumor effects of FUra and to activation of host defense mechanisms by the r-IFN-.

¹ This work was supported in part by Grant R35-CA 42107 from the National Cancer Institute, NIH, and by the AMOCO Foundation.

² To whom requests for reprints should be addressed, at Department of Cell Biology (HMB 173), M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 4/ 8/88. Revised 10/18/88. Accepted 11/ 7/88.

This article has been cited by other articles:

				E. A. Choi, H. Lei, D. J. Maron, R. Mick, J. Barsoum, Q.-c. Yu, D. L. Fraker, J. M. Wilson, and F. R. Spitz Combined 5-Fluorouracil/Systemic Interferon-{beta} Gene Therapy Results in Long-Term Survival in Mice with Established Colorectal Liver Metastases Clin. Cancer Res., February 15, 2004; 10(4): 1535 - 1544. [Abstract] [Full Text] [PDF]